Mukesh Kumar

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (15)

• Data from MECP2-Dependent Cancers Can Be Targeted by Epigenetic Drugs: A New Role for Epigenetic Cancer Therapy
  2026 DOI: 10.1158/1535-7163.c.8542698
  +Save
• Supplementary Figure S1 from MECP2-Dependent Cancers Can Be Targeted by Epigenetic Drugs: A New Role for Epigenetic Cancer Therapy
  2026 DOI: 10.1158/1535-7163.32714244
  +Save
• Supplementary Figure S2 from MECP2-Dependent Cancers Can Be Targeted by Epigenetic Drugs: A New Role for Epigenetic Cancer Therapy
  2026 DOI: 10.1158/1535-7163.32714241
  +Save
• MECP2-Dependent Cancers Can Be Targeted by Epigenetic Drugs: A New Role for Epigenetic Cancer Therapy
  Molecular Cancer Therapeutics 2026 DOI: 10.1158/1535-7163.MCT-25-0603
  +Save
• A systematic review of computer simulation modelling methods in optimizing acute ischemic stroke treatment services
  IISE Transactions on Healthcare Systems Engineering 2024 DOI: 10.1080/24725579.2024.2322959
  +Save
• CAR-T cell therapy: a game-changer in cancer treatment and beyond.
  Kumar Utkarsh, Namita Srivastava, Sachin Kumar +5 more
  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2024 DOI: 10.1007/s12094-023-03368-2
  +Save
• Therapeutic antibodies for the prevention and treatment of cancer.
  Journal of biomedical science 2024 DOI: 10.1186/s12929-024-00996-w
  +Save
• A drug combination targeting hypoxia induced chemoresistance and stemness in glioma cells
  Akansha Jalota, Mukesh Kumar, Bhudev Chandra Das +3 more
  Oncotarget 2018 DOI: 10.18632/oncotarget.24839
  +Save
• Application of oncolytic virus as a therapy of cancer
  Microbial Biotechnology 2018 DOI: 10.1007/978-981-10-7140-9_17
  +Save
• Stromal cyclin D1 promotes heterotypic immune signaling and breast cancer growth
  Timothy G. Pestell, Xuanmao Jiao, Mukesh Kumar +21 more
  Oncotarget 2017 DOI: 10.18632/oncotarget.19953
  +Save
• Synergistic increase in efficacy of a combination of 2-deoxy-d-glucose and cisplatin in normoxia and hypoxia: switch from autophagy to apoptosis
  Akansha Jalota, Mukesh Kumar, Bhudev Chandra Das +3 more
  Tumor Biology 2016 DOI: 10.1007/s13277-016-5089-8
  +Save
• A novel placental like alkaline phosphate promoter driven transcriptional silencing combined with single chain variable fragment antibody based virosomal delivery for neoplastic cell targeting
  Imran Khan, Mohammad Khalid Zakaria, Mukesh Kumar +4 more
  Journal of Translational Medicine 2015 DOI: 10.1186/s12967-015-0602-1
  +Save
• Membrane fusion mediated targeted cytosolic drug delivery through SCFV engineered sendai viral envelopes
  M. Kumar, Priyanka Mani, P. Pratheesh +5 more
  Current Molecular Medicine 2015 DOI: 10.2174/1566524015666150505155949
  +Save
• Nature of Immobilization Surface Affects Antibody Specificity to Placental Alkaline Phosphatase
  Mukesh Kumar, Imran Khan, Subrata Sinha
  Journal of Immunoassay and Immunochemistry 2015 DOI: 10.1080/15321819.2014.973117
  +Save
• Epigenetic drugs inhibit the oncogenic activity of methyl CpG binding protein 2 (MECP2)
  +Save